quinazolines has been researched along with Brain Swelling in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batchelor, TT; di Tomaso, E; Duda, DG; Duyverman, AM; Farrar, CT; Fukumura, D; Jain, RK; Kamoun, WS; Lacorre, DA; Lahdenranta, J; Ley, CD; Munn, LL; Sorensen, AG | 1 |
Batchelor, TT; di Tomaso, E; Duda, DG; Gerstner, ER; Ivy, P; Jain, RK; Loeffler, JS; Ryg, PA; Sorensen, AG | 1 |
Kim, CH; Ma, Q; Manaenko, A; Sun, X; Yan, J; Zhang, JH | 1 |
Ancukiewicz, M; Batchelor, TT; Benner, T; Cahill, DP; Chen, PJ; Cohen, KS; di Tomaso, E; Drappatz, J; Duda, DG; Ivy, P; Jain, RK; Kozak, KR; Loeffler, JS; Louis, DN; Mrugala, MM; Plotkin, S; Scadden, DT; Sorensen, AG; Wen, PY; Zhang, WT; Zhu, M | 1 |
Chang, S; Cloughesy, T; Dancey, J; Fink, K; Junck, L; Kuhn, J; Prados, MD; Robins, HI; Wen, PY; Yung, WK | 1 |
Hara, H; Kato, H; Kogure, K; Ozaki, A; Sukamoto, T | 1 |
1 review(s) available for quinazolines and Brain Swelling
Article | Year |
---|---|
VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer.
Topics: Brain Edema; Brain Neoplasms; Humans; Magnetic Resonance Imaging; Neovascularization, Pathologic; Quinazolines; Vascular Endothelial Growth Factor A | 2009 |
2 trial(s) available for quinazolines and Brain Swelling
Article | Year |
---|---|
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.
Topics: Brain Edema; Brain Neoplasms; Chemokine CXCL12; Chemokines, CXC; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Fibroblast Growth Factors; Flow Cytometry; Glioblastoma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplastic Cells, Circulating; Neoplastic Stem Cells; Neovascularization, Pathologic; Protein Kinase Inhibitors; Quinazolines; Receptors, Vascular Endothelial Growth Factor; Survival Analysis | 2007 |
Phase-1 trial of gefitinib and temozolomide in patients with malignant glioma: a North American brain tumor consortium study.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Brain Edema; Brain Neoplasms; Dacarbazine; Dose-Response Relationship, Drug; Female; Gefitinib; Glioblastoma; Glioma; Humans; Karnofsky Performance Status; Male; Middle Aged; Quinazolines; Temozolomide | 2008 |
3 other study(ies) available for quinazolines and Brain Swelling
Article | Year |
---|---|
Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in mice.
Topics: Animals; Antineoplastic Agents; Brain Edema; Brain Neoplasms; Glioblastoma; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Magnetic Resonance Imaging; Mice; Mice, Nude; Protein Kinase Inhibitors; Quinazolines; Receptors, Vascular Endothelial Growth Factor; Xenograft Model Antitumor Assays | 2009 |
PAR-1 antagonist SCH79797 ameliorates apoptosis following surgical brain injury through inhibition of ASK1-JNK in rats.
Topics: Animals; Apoptosis; Blotting, Western; Brain; Brain Edema; Brain Injuries; Immunohistochemistry; Intraoperative Complications; Male; MAP Kinase Kinase 4; MAP Kinase Kinase Kinase 5; Neurosurgical Procedures; Pyrroles; Quinazolines; Rats; Rats, Sprague-Dawley; Receptor, PAR-1; Thrombin | 2013 |
Amelioration of brain damage after focal ischemia in the rat by a novel inhibitor of lipid peroxidation.
Topics: Animals; Brain; Brain Edema; Brain Injuries; Brain Ischemia; Cerebral Arteries; Glycerol; In Vitro Techniques; Lipid Peroxidation; Male; Mitochondria; Mitochondrial Swelling; Quinazolines; Rats; Rats, Inbred Strains | 1991 |